Hiers Enterprises, LLC dba Northwest Compounding Pharmacy recalls Hydroxyprogesterone liquid, 250mg/ml, RX, glass vial
- Recall date
- January 2, 2019
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0396-2019
- FDA classification
- Class II
- Brand / firm
- Hiers Enterprises, LLC dba Northwest Compounding Pharmacy
- Sold / distributed
- Product was distributed exclusively in the state of Oregon to 3 Medical facilities, 1 Physician's office and 80 consumers/patients. These are compounded products - labels vary for each compound - specific to each patient. Firm did not provide labeling.
Why it was recalled
Lack of sterility assurance.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Hydroxyprogesterone liquid, 250mg/ml, RX, glass vial
Get recall alerts
Free email alert whenever Hiers Enterprises, LLC dba Northwest Compounding Pharmacy has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Hiers Enterprises, LLC dba Northwest Compounding Pharmacy